Abstract

AimsWe aimed to assess whether vitamin D supplementation improves glucose metabolism in adults with type 2 diabetes. MethodsPubMed and Cochrane database were searched up to July 1st 2016 for randomized controlled trials that assessed the relationship between vitamin D supplementation and glucose metabolism (change in hemoglobin A1C (HbA1C) and fasting blood glucose (FBG)) among adults with type 2 diabetes. ResultsTwenty nine trials (3324 participants) were included in the systematic review. Among 22 studies included in the meta-analysis, 19 reported HbA1C, 16 reported FBG outcomes and 15 were deemed poor quality. There was a modest reduction in HbA1C (−0.32% [−0.53 to −0.10], I2=91.9%) compared to placebo after vitamin D supplementation but no effect on FBG (−2.33mg/dl [−6.62 to 1.95], I2=59.2%). In studies achieving repletion of vitamin D deficiency (n=7), there were greater mean reductions in HbA1C (−0.45%, [−1.09 to 0.20]) and FBG (−7.64mg/dl [−16.25 to 0.97]) although not significant. ConclusionsWe found a modest reduction of HbA1C after vitamin D treatment in adults with type 2 diabetes albeit with substantial heterogeneity between studies and no difference in FBG. Larger studies are needed to further evaluate the glycemic effects of vitamin D treatment especially in patients with vitamin D deficiency.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call